19 - 20 November, 2019 | London, UK

Dr Sven Bostyn Lic.Jur., LLM, PhD

Associate Professor of Biomedical Innovation Law
Law Center for Advanced studies in Biomedical Innovation Law

Regulatory Challenges to Life Science IP's

Tuesday, November 27th, 2018

13:15 Plausibility – An Ancillary or Independent Patentability Requirement

This session will cover the following topics:
Sufficiency vs. Inventive Step
European Case Law examples
UK Supreme Court battles (Warner-Lambert vs. Actavis/Pregabalin)
Fairness and Practicality

Effective IP Management and Monetisation Strategies

Monday, November 28th, 2078

11:30 Patenting Antibodies – Another Problematic Area?

Is there anything special about patenting antibodies?
Contested area of law – Pharmaceuticals moving away from chemical products and more towards biotech products
Previously, patents were granted generously, with broad scope – Since screening has improved, requirement to prove more defined antibodies to secure protection
How to overcome the issue of inventiveness?

Check out the incredible speaker line-up to see who will be joining Sven.

Download The Latest Agenda